"24001" . "\u017Durek, Martin" . "Syst\u00E9mov\u00FD lupus erythematodes (SLE) je autoimunitn\u00ED onemocn\u011Bn\u00ED chrakteristick\u00E9 sv\u00FDm multiorg\u00E1nov\u00FDm posti\u017Een\u00EDm. Kardiovaskul\u00E1rn\u00ED posti\u017Een\u00ED zauj\u00EDm\u00E1 prvn\u00ED m\u00EDsto v mortalit\u011B pacient\u016F se SLE. Nej\u010Dast\u011Bj\u0161\u00ED jsou perikarditida, chlopenn\u00ED vady, p\u0159evodn\u00ED poruchy a arteri\u00E1ln\u00ED hypertenze. V men\u0161\u00ED m\u00ED\u0159e se vyskytuje tak\u00E9 plicn\u00ED hypertenze a koron\u00E1rn\u00ED arteriitida. \u017Diln\u00ED tromb\u00F3za se v p\u0159\u00EDm\u00E9 souvislosti se SLE objevuje asi v 10%. Velmi d\u016Fle\u017Eit\u00FDm jevem je akcelerace ateroskler\u00F3zy a jej\u00ED n\u00E1sledn\u00E9 kardiocerebr\u00E1ln\u00ED p\u0159\u00EDhody. Nej\u010Dast\u011Bji jde o infarkt myokardu (IM), c\u00E9vn\u00ED mozkovou p\u0159\u00EDhodu (CMP), tromboembolii (TEN), srde\u010Dn\u00ED selh\u00E1n\u00ED a tak\u00E9 n\u00E1hlou smrt. Tato pr\u00E1ce sleduje v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod a jejich vztah k vybran\u00FDm rizikov\u00FDm faktor\u016Fm v kohort\u011B pacient\u016F se SLE sledovan\u00FDch v jednom klinick\u00E9m centru (III. intern\u00ED klinika, LF UP a FN Olomuc)." . "6"^^ . . "2" . . . "Cardiovascular events in patients with systemic lupus erythematosus"@en . "Kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody u pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes" . . "I" . . "Sk\u00E1celov\u00E1, Martina" . "Cor et Vasa" . "CZ - \u010Cesk\u00E1 republika" . . . . . "thromboembolic event; systemic lupus erythematosus; myocardial infarction; intima-media thickness; cerebrovascular event; cardiovascular event; arterial hypertension"@en . . . . "Vaverkov\u00E1, Helena" . "Syst\u00E9mov\u00FD lupus erythematodes (SLE) je autoimunitn\u00ED onemocn\u011Bn\u00ED chrakteristick\u00E9 sv\u00FDm multiorg\u00E1nov\u00FDm posti\u017Een\u00EDm. Kardiovaskul\u00E1rn\u00ED posti\u017Een\u00ED zauj\u00EDm\u00E1 prvn\u00ED m\u00EDsto v mortalit\u011B pacient\u016F se SLE. Nej\u010Dast\u011Bj\u0161\u00ED jsou perikarditida, chlopenn\u00ED vady, p\u0159evodn\u00ED poruchy a arteri\u00E1ln\u00ED hypertenze. V men\u0161\u00ED m\u00ED\u0159e se vyskytuje tak\u00E9 plicn\u00ED hypertenze a koron\u00E1rn\u00ED arteriitida. \u017Diln\u00ED tromb\u00F3za se v p\u0159\u00EDm\u00E9 souvislosti se SLE objevuje asi v 10%. Velmi d\u016Fle\u017Eit\u00FDm jevem je akcelerace ateroskler\u00F3zy a jej\u00ED n\u00E1sledn\u00E9 kardiocerebr\u00E1ln\u00ED p\u0159\u00EDhody. Nej\u010Dast\u011Bji jde o infarkt myokardu (IM), c\u00E9vn\u00ED mozkovou p\u0159\u00EDhodu (CMP), tromboembolii (TEN), srde\u010Dn\u00ED selh\u00E1n\u00ED a tak\u00E9 n\u00E1hlou smrt. Tato pr\u00E1ce sleduje v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod a jejich vztah k vybran\u00FDm rizikov\u00FDm faktor\u016Fm v kohort\u011B pacient\u016F se SLE sledovan\u00FDch v jednom klinick\u00E9m centru (III. intern\u00ED klinika, LF UP a FN Olomuc)."@cs . "56" . "Kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody u pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes"@cs . "15110" . . "Kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody u pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes"@cs . "Fry\u0161\u00E1kov\u00E1, Ladislava" . "Cardiovascular events in patients with systemic lupus erythematosus"@en . "Hor\u00E1k, Pavel" . "Kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody u pacient\u016F se syst\u00E9mov\u00FDm lupus erythematodes" . "[8A62D0CE5744]" . . . "3"^^ . . . . . "8"^^ . "RIV/61989592:15110/14:33150015!RIV15-MSM-15110___" . "0010-8650" . "RIV/61989592:15110/14:33150015" . . "Smr\u017Eov\u00E1, Andrea" . "Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by multiorgan impairment. Cardiovascular involvement represents the leading cause of mortality in SLE patients. Its most common manifestations include pericarditis, valvular afections, conduction disorders, and arterial hypertension. Pulmonary hypertension and coronary arteritis are seen less often. Venous thrombosis directly related to SLE affects about 10% of SLE cases. Acceleration of atherosclerosis is very important and arterial hypertension. Pulmonary hypertension and coronary arteritis are seen less often. Venous thrombosis directly related to SLE affects about 10% of SLE cases. Acceleration of atherosclerosis is very important and so are the ensuing cardiocerebral events, the most common of those being myocardial infarctions (MIs), cerebrovascular events, thromboembolic events (TEs), heart failure, and sudden death. We analyzed the frequency of cardiovascular events and their relationship to selected risk factors in a cohort of SLE patients followed in a single clinical center (Third Department of Internal Medicine, Faculty Hospital of Palack\u00FD University, Olomouc)."@en .